Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 34, 2012 - Issue 6
Submit an article Journal homepage
216
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies

Gino A. VenaDepartment of Biomedical Sciences and Human Oncology, Unit of Dermatology and Venereology, University of Bari, Bari, ItalyCorrespondence[email protected]
,
Nicoletta CassanoDepartment of Biomedical Sciences and Human Oncology, Unit of Dermatology and Venereology, University of Bari, Bari, Italy
,
Stefano PiasericoDepartment of Dermatology, University of Padua, Padua, Italy
,
Andrea ContiUnit of Dermatology, Azienda Ospedaliera Universitaria Policlinico, Modena, Italy
&
Giampiero GirolomoniDepartment of Dermatology, University of Verona, Verona, Italy
Pages 901-906 | Received 05 Apr 2012, Accepted 07 May 2012, Published online: 11 Jun 2012

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yimeng Gao & Hongzhong Jin. (2022) Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis. Journal of Dermatological Treatment 33:1, pages 178-183.
Read now
Siegfried Segaert, Pierre-Dominique Ghislain & Caroline Boone. (2016) An observational study of the real-life management of psoriasis patients treated with etanercept according to the new reimbursement criteria (in Belgium). Journal of Dermatological Treatment 27:2, pages 103-109.
Read now

Articles from other publishers (1)

M. Esposito, P. Gisondi, N. Cassano, G. Ferrucci, M. Del Giglio, F. Loconsole, A. Giunta, G.A. Vena, S. Chimenti & G. Girolomoni. (2013) Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study. British Journal of Dermatology 169:3, pages 666-672.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.